Concepedia

Robert Kleszcz

RK

Statistics

Publications

22

Citations

568

H-Index

16

Active since

2013

Affiliations

Poznan University of Medical Sciences(Current)

Heliodor Swiecicki Clinical Hospital

Adam Mickiewicz University in Poznań

Robert Kleszcz is an author at Poznan University of Medical Sciences specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2013–2024

22

Publications

22

Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients

Aleksandra Majchrzak‐Celińska, Jarosław Paluszczak, Robert Kleszcz et al. · Journal of Applied Genetics · 2013 · 76 citations · Full text

, , +17

Lichen-derived caperatic acid and physodic acid inhibit Wnt signaling in colorectal cancer cells

Jarosław Paluszczak, Robert Kleszcz, Elżbieta Studzińska-Sroka et al. · Molecular and Cellular Biochemistry · 2017 · 64 citations · Full text

, , +16

Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells

Robert Kleszcz, Anna Szymańska, Violetta Krajka‐Kuźniak et al. · Cellular Oncology · 2019 · 43 citations · Full text

, , +16

Combination of xanthohumol and phenethyl isothiocyanate inhibits NF-κB and activates Nrf2 in pancreatic cancer cells

Violetta Krajka‐Kuźniak, Marta Cykowiak, Hanna Szaefer et al. · Toxicology in Vitro · 2020 · 39 citations

, , +13

COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells

Aleksandra Majchrzak‐Celińska, Julia O. Misiorek, Nastassia Kruhlenia et al. · BMC Cancer · 2021 · 37 citations · Full text

, , +16

1–5 of 22